< 聚焦癌症与传染病研究 - Fluidigm网络大会诚邀您的参与

image.png


Fluidigm于2020年7月7日在Labroots举办的在线网络大会,会上将Fluidigm质谱流式技术、微流控技术及激光捕获显微切割技术在癌症与传染病研究领域的应用和发展进行深入探讨。



20200708796948.jpg


(中国大陆用户建议使用LinkedIn账户关联注册)


我们很荣幸邀请到以下在传染病、肿瘤及肿瘤免疫研究领域颇有建树的专家学者,在会上与大家分享他们的最新研究成果。


演讲嘉宾


Burkhard Becher, PhD, University of Zurich
Single-cell mapping of human brain cancer reveals tumor-driven education of tumor
associated leukocytes


Noel de Miranda, PhD, Leiden University Medical Center
Deep immunophenotyping of cancer microenvironments by Imaging Mass Cytometry™

Evan Newell, PhD, Fred Hutchinson Cancer Research Center
Deciphering T cell heterogeneity in humans through analysis of antigen-specificity

Richard Head, MS, Washington University School of Medicine at St. Louis
Development of an extraction-free, saliva-based workflow for SARS-CoV-2 detection with the Biomark™ HD platform

Patrick Reeves, PhD, Massachusetts General Hospital
Mass cytometry in vaccine development: utility and considerations

Kurt Schalper, MD, PhD, Yale Cancer Center
Evaluating tumor-immune cell interactions in human lung cancer using multiparametric and spatially resolved tissue analysis

David Novo, PhD, De Novo™ Software
Visualization and analysis of high-parameter CyTOF® data with FCS Express™ in record time

Hema Kothari, PhD, University of Virginia
Identification of human immune cell subtypes most vulnerable to IL-1β-induced inflammatory signaling using mass cytometry

Hiroyoshi Nishikawa, MD, PhD, National Cancer Center Japan
Comprehensive landscape of the tumor microenvironment analyzed with CyTOF technology


想了解Fluidigm产品与技术的最新进展吗?赶快点击观看讲座回放吧!


   ●  了解我们的COVID研究和检测解决方案,包括我们向美国FDA提交的Advanta™ DXSARS-CoV-2 RT-PCR Assay的紧急使用授权(EUA),这是一种基于唾液的免萃取物检测方法,可快速检测SARS-CoV2病毒。


   ●  了解新的AccuLift™激光捕获显微切割系统,该系统使研究人员能够捕获肿瘤微环境中的指定区域或单个细胞,揭示独特的分子特征,获得空间生物学新见解


   ●  抢先了解Fluidigm的新产品-专为改进流式和质谱样品制备工作流程而设计的自动化样品制备系统。


20200708796948.jpg


如需了解更多信息,欢迎联系我们




下一篇:Acculift 激光捕获显微切割系统助您深度剖析组织微环境

访问统计:565865